Hermes Biosciences
Latest round
- Seed
Last raised
- Nov 2025
Total raised
- Undisclosed
Investors
- 3
About Hermes Biosciences
Hermes Biosciences is dedicated to advancing the field of exosome research through the development of its specialized benchtop isolation system. The company was founded to address the growing demand for efficient exosome purification methods. Its headquarters are located in the United States and it has conducted two investment deals since inception.Hermes Biosciences specializes in the development of a benchtop, hands-off extracellular vesicle isolation system designed to purify exosomes from various biological fluids and cell culture media. This technology enables researchers to process samples quickly and efficiently, facilitating deeper understanding of exosome functions and their applications in clinical fields such as oncology, degenerative diseases, and regenerative medicine.The revenue model of Hermes Biosciences is structured around direct sales of its exosome isolation systems to research institutions and clinical laboratories through procurement agreements. Clients purchase the equipment alongside related consumables and support services. The primary product has established a foothold in the market, appealing to both B2B transactions and research collaborations.Hermes Biosciences plans to expand its product offerings with new exosome isolation systems and aims to penetrate additional markets in Europe and Asia by 2025.
Who invested in Hermes Biosciences
3 investors across 1 round
See all investors in Hermes Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 18, 2025
Amount
Undisclosed
Investors
Questions about Hermes Biosciences
Who invested in Hermes Biosciences?
Hermes Biosciences has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hermes Biosciences raised?
Hermes Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hermes Biosciences last raise money?
Hermes Biosciences's most recent round on record is a Seed, in Nov 2025.
What does Hermes Biosciences do?
Hermes Biosciences is dedicated to advancing the field of exosome research through the development of its specialized benchtop isolation system.
Where is Hermes Biosciences headquartered?
Hermes Biosciences is headquartered in US.
Which VCs invest in companies like Hermes Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Hermes Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Hermes Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.